House voices support for rare cancer research funding
H.Res. 1081 — Raising awareness for the sarcoma cancer chordoma. · Filed by Hank Johnson (D-GA) · 1 cosponsor · Introduced Feb 25, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This is a non-binding resolution expressing the House's view that chordoma (a rare, aggressive bone cancer) patients and families need increased funding and support for diagnosis, treatment development, and research. It does not appropriate money, create programs, or change law—it is a statement of congressional sentiment.
Why we flagged it
This is a simple, non-binding congressional resolution expressing support for increased funding and research into a rare cancer. It contains no operative mechanism, appropriation, or policy change—only a statement of the House's sense on the matter.
Who it affects
The resolution itself changes no law and appropriates no money, so it imposes no direct cost on citizens. However, it also confers no direct benefit—it is a messaging statement.